IP Library Granted Patent US 8,646,445
Granted Patent B2
US 8,646,445 · App. 12/951,811 · Granted Feb 11, 2014

Nitric oxide delivery system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,646,445
App. No.
12/951,811
Granted
Feb 11, 2014
Kind
B2
Abstract

An ambulatory or stationary device for delivery of a therapeutic amount of nitric oxide to an individual's lungs.

Claims (53)

1. A system for delivering a therapeutic amount of nitric oxide, comprising:

a liquid reservoir containing dinitrogen tetroxide;

a tube coupled to the reservoir;

a first ribbed tube coupled to the tube, wherein the first ribbed tube comprises:

a plurality of hollow ribs,

wherein each rib comprises a volume, a base and a length that is a distance across the base of the rib; and

a surface-active material with a reducing agent, wherein a volume of the surface-active material is within each rib and a height of the surface-active material within each rib is a distance above the base of each rib the surface-active material extends into the rib, and wherein the length of each rib is less than twice the distance above the base of each rib the surface-active material extends into the rib, and the volume of each rib is greater than the volume of the surface-active material within each rib; and

a patient interface coupled to the first ribbed tube, wherein the first ribbed tube is configured to convert nitrogen dioxide in a gas flow into nitric oxide prior to reaching the patient interface.

2. The system of claim 1 , wherein the tube coupled to the reservoir is a quartz tube.

3. The system of claim 1 , wherein the tube coupled to the reservoir is silica tube.

4. The system of claim 1 , wherein the tube coupled to the reservoir has a bore size of about 50 microns.

5. The system of claim 1 , wherein the tube coupled to the reservoir has a bore size of about 25 microns or less.

6. The system of claim 1 , wherein the tube coupled to the reservoir has a bore size of 10 microns or less.

7. The system of claim 1 , wherein the tube coupled to the reservoir is sealed before use.

8. The system of claim 1 , further comprising an air pump in communication with the reservoir.

9. The system of claim 8 , wherein the pump is a battery-driven pump.

10. The system of claim 1 , wherein the patient interface is a mouth piece, nasal cannula, face mask, fully-sealed face mask or an endotracheal tube.

11. The system of claim 1 , wherein the reservoir contains compressed nitrogen dioxide with or without a diluent gas.

12. The system of claim 1 , wherein the reservoir further includes nitrogen, air, oxygen-enriched air, or substantially pure oxygen.

13. The system of claim 1 , wherein the surface-active material is a silica gel.

14. The system of claim 1 , further comprising a second ribbed tube coupled to the first ribbed tube, the second ribbed tube comprising a surface-active material and a reducing agent.

15. The system of claim 1 , wherein the patient interface is a delivery tube adapted to deliver the gas flow to the patient's mouth or nose or an endotracheal tube attached to a ventilator or an anesthesia machine.

16. The system of claim 1 , wherein the reservoir is spherical.

17. The system of claim 1 , wherein the reservoir is a fused silica reservoir.

18. The system of claim 1 , wherein the reservoir is a non-reactive metal reservoir.

19. The system of claim 18 , wherein the non-reactive metal is palladium, silver, platinum, gold, aluminum or stainless steel.

20. The system of claim 18 , wherein the reservoir is an aluminum reservoir.

21. The system of claim 18 , wherein the reservoir is a stainless steel reservoir.

22. The system of claim 1 , further comprising an insulation covering the reservoir and the tube coupled to the reservoir.

23. The system of claim 22 , wherein the insulation covering further comprises an alkaline solution.

24. The system of claim 23 , wherein the alkaline solution is calcium oxide, sodium hydroxide, sodium carbonate, potassium hydroxide, ammonium hydroxide, or sodium silicate.

25. The system of claim 1 , wherein the gas is air or oxygen.

26. The system of claim 1 , wherein the reducing agent is an antioxidant.

27. The system of claim 26 , wherein the antioxidant is an aqueous solution of an antioxidant.

28. The system of claim 26 , wherein the antioxidant is ascorbic acid, alpha tocopherol, or gamma tocopherol.

29. A device for delivering nitric oxide to a patient comprising:

a liquid reservoir containing dinitrogen tetroxide;

a tube coupled to the reservoir, wherein the tube coupled to the reservoir has a bore size of about 25 microns or less;

a first ribbed tube coupled to the tube, the first ribbed tube comprising a surface-active material saturated with an aqueous solution of an antioxidant and a plurality of ribs, wherein the volume within each rib is greater than the a volume of the surface-active material within each rib

a plurality of hollow ribs, wherein each rib comprises a volume, a base and a length that is a distance across the base of the rib; and

a surface-active material saturated with an aqueous solution of an antioxidant, wherein a volume of the surface-active material is within each rib and a height of the surface-active material within each rib is a distance above the base of each rib the surface-active material extends into the rib, and the length of each rib is less than twice the distance above the base of each rib the surface-active material extends into the rib, and the volume of each rib is greater than the volume of the surface-active material within each rib; and

a patient interface coupled to the first ribbed tube, wherein the first ribbed tube is configured to convert nitrogen dioxide in a gas flow into nitric oxide prior to reaching the patient interface.

30. The device of claim 29 , comprising an air pump in communication with the reservoir.

31. The device of claim 29 , wherein the pump is a battery-driven pump.

32. The device of claim 29 , further comprising a nitrogen dioxide and/or a nitric oxide sensor.

33. The device of claim 32 , wherein the nitrogen dioxide and/or nitric oxide sensor is calibrated automatically at periodic time intervals.

34. A ribbed tube comprising a body having a first end and a second end, wherein the body comprises

multiple hollow concentric ribs, wherein each rib comprises a base and a length that is a distance across the base of the rib, and each rib comprises a volume; and

a surface-active material, wherein a volume of the surface-active material is within each rib and a height of the surface-active material within each rib is a distance above the base of each rib the surface-active material extends into the rib, and wherein the length of each rib is less than twice the distance above the base of each rib the surface-active material extends into the rib, and the volume of each rib is greater than the volume of the surface-active material within each rib.

35. The tube of claim 34 , wherein the surface-active material is saturated with an aqueous solution of an antioxidant.

36. The tube of claim 34 , wherein the surface-active material comprises a silica gel, activated charcoal, activated carbon, activated alumina or calcium sulfate.

37. The tube of claim 34 , further comprising a reducing agent.

38. The tube of claim 35 , wherein the reducing agent is an antioxidant.

Assignments (4)
SECURITY INTEREST Recorded Mar 16, 2026
From: VERO BIOTECH INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 075117/0935 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2011
From: FINE, DAVID H.; VASQUEZ, GREGORY; JOHNSON, BRYAN; FULLER, JODY; DENTON, RYAN
To: GENO LLC
Reel/Frame 026443/0466 →